4 completed, 1 unknown. 1 Not applicable, 1 Phase 2, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
| Phase 4 | 1 | Completed 1 |
Follow Ampel BioSolutions, LLC: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Relationship Between Data Obtained With the LuGENE® Multiparameter Transcriptomics Blood Test and Clinical and Standard Laboratory Features of Patients With SLE (ReLATE) Decision Support Test - Lupus Erythematosus, Systemic | Unknown | Ampel BioSolutions, LLC | 200 | 2023-12-19 | 2024-05-03 | |
| Omega-3 Replacement With Krill Oil in Disease Management of SLE AKBM-3031, Placebo - Systemic Lupus Erythematosus (SLE) | Not applicable | Completed | Aker BioMarine Human Ingredients AS | 76 | 2018-10-23 | 2021-10-12 |
| A Crossover Study to Compare RAYOS to IR Prednisone to Improve Fatigue and Morning Symptoms for SLE RAYOS, Prednisone - Lupus Erythematosus, Systemic, Lupus Erythematosus | Phase 4 | Completed | Ampel BioSolutions, LLC | 62 | 2017-09-12 | 2020-07-08 |
| Validation of a Mobile Phone Based on EPRO Tool in Subjects With Systemic Lupus Erythematosus No Medical Intervention - SLE, Lupus Erythematosus, Systemic | Completed | Lupus Research Alliance | 80 | 2017-08-21 | 2023-11-07 | |
| Tolerization Reduces Intolerance to Pegloticase and Prolongs the Urate Lowering Effect Pegloticase, Azathioprine - Gout | Phase 2 | Completed | Ampel BioSolutions, LLC | 132 | 2015-12-01 | 2021-10-11 |
Lupus Erythematosus, Systemic (4) · Fatigue (1) · Gout (1)
Azathioprine (1) · Pegloticase (1) · Prednisone (1)
United States (5) · Canada (2)